Qualitative study of antibiotic prescription patterns and associated drivers in Sudan, Guinea-Bissau, Central African Republic and Democratic Republic of Congo.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
24 09 2020
Historique:
entrez: 25 9 2020
pubmed: 26 9 2020
medline: 15 5 2021
Statut: epublish

Résumé

The objective of this study was to address the knowledge gap regarding antibiotic use in Medecins Sans Frontiéres (MSF) projects located in Africa by exploring antibiotic prescription and consumption habits and their drivers at different healthcare levels. This study used an exploratory study design through thematic analysis of semistructured, in-depth interviews, focus group discussions (FGDs) and field observations in order to understand the main drivers influencing current antibiotics prescription habits and consumption habits of patients in different geographical settings. The study took place in MSF centres and towns across four countries: Guinea-Bissau, Central African Republic (CAR), Democratic Republic of Congo (DRC) and Sudan. 384 respondents participated in the study, which includes project staff, prescribers, community members, patients, among other groups. Treatment protocols were physically present in all countries except DRC, but compliance to protocols varied across contexts. A failing health system and barriers to accessing healthcare were perceived as major drivers of overuse and inconsistent prescription practices. Patient demands influenced prescription decisions, and self-medication was commonly reported in the context of failing health systems. Additionally, there was a strong demand for quick cures and communities preferred injections over pills. Patients tended to stop antibiotic treatment once symptoms abated and had major gaps in understanding antibiotic intake instructions and functions. While there were specific findings in each context, the larger trend from these four MSF projects in Africa indicates widespread use of antibiotics based on unclear assumptions, which are often influenced by patient demands. There needs to be a broader focus on the balance between access and excess, especially in such fragile contexts where access to healthcare is a real challenge.

Identifiants

pubmed: 32973055
pii: bmjopen-2019-036530
doi: 10.1136/bmjopen-2019-036530
pmc: PMC7517544
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e036530

Informations de copyright

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Afr J Lab Med. 2018 Dec 06;7(2):924
pubmed: 30568909
Clin Infect Dis. 2011 Oct;53(7):677-85
pubmed: 21890771
Lancet Infect Dis. 2016 Sep;16(9):1017-1025
pubmed: 27312577
Int J Health Sci (Qassim). 2018 May-Jun;12(3):18-24
pubmed: 29896067
Lancet Infect Dis. 2005 Aug;5(8):481-93
pubmed: 16048717
Antibiotics (Basel). 2017 Oct 31;6(4):
pubmed: 29088074
Clin Infect Dis. 2019 Oct 30;69(Suppl 6):S449-S458
pubmed: 31665776
J Glob Antimicrob Resist. 2019 Jun;17:132-136
pubmed: 30557686
PLoS One. 2019 Jun 27;14(6):e0219002
pubmed: 31247028
Lancet. 2016 Jan 9;387(10014):102-4
pubmed: 26603923
BMJ Open. 2019 May 14;9(5):e026193
pubmed: 31092653
JAMA Intern Med. 2016 Jan;176(1):21-9
pubmed: 26719947
PLoS One. 2019 May 31;14(5):e0217818
pubmed: 31150515
BMJ. 2014 Mar 06;348:g1606
pubmed: 24603565
BMC Infect Dis. 2017 Sep 11;17(1):616
pubmed: 28893183
PLoS One. 2018 Dec 20;13(12):e0208447
pubmed: 30571688
JAMA. 2006 Sep 13;296(10):1235-41
pubmed: 16968847
Antimicrob Resist Infect Control. 2019 Jan 30;8:23
pubmed: 30733857
Pediatrics. 2008 May;121(5):e1352-6
pubmed: 18450878
BMC Res Notes. 2014 Jun 18;7:374
pubmed: 24943866

Auteurs

Tonka Eibs (T)

Vienna Evaluation Unit, Medecins Sans Frontieres, Vienna, Austria.

Alena Koscalova (A)

Vienna Evaluation Unit, Medecins Sans Frontieres, Vienna, Austria alena.koscalova@gmail.com.

Mohit Nair (M)

Vienna Evaluation Unit, Medecins Sans Frontieres, Vienna, Austria.

Paul Grohma (P)

Infectious diseases departement, Slovak Medical University, Bratislava, Slovakia.

Gisa Kohler (G)

Vienna Evaluation Unit, Medecins Sans Frontieres, Vienna, Austria.

Rawa Gafar Bakhit (RG)

Vienna Evaluation Unit, Medecins Sans Frontieres, Vienna, Austria.

Mzia Thurashvili (M)

Vienna Evaluation Unit, Medecins Sans Frontieres, Vienna, Austria.

Estrella Lasry (E)

Medical departement, Medecins Sans Frontieres, Barcelona, Spain.

Sandra Wagner Bauer (SW)

Vienna Evaluation Unit, Medecins Sans Frontieres, Vienna, Austria.

Carolina Jimenez (C)

Medical departement, Medecins Sans Frontieres, Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH